Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Medical Device Recalls
  • Print
  • Share
  • E-mail
-
1 to 5 of 5 Results
Related Medical Device Recalls Recall Date to: 07/07/2015
Results per Page
New Searchexport reports to excelExport to Excel | HelpHelp
Product Description
Sort by Product Name [A-Z]
Sort by Product Name [Z-A]
Recall
Class
Sort by Recall Class [0-9]
Sort by Recall Class [9-0]
FDA Recall
Posting Date
Sort by Date Classified [0-9]
Sort by Date Classified [9-0]
Recalling Firm
Sort by Recalling Firm [A-Z]
Sort by Recalling Firm [Z-A]
Z-1507-2013 - FLEXSTENT Biliary Self-Expanding Stent System. Product Usage: The FSS FLEXSTENT Biliary SES product is indicated for use in the palliation of malignant strictures in the biliary tree. 2 06/06/2013 Cordis Corporation
Z-1508-2013 - FLEXSTENT Femoropopliteal Self-Expanding Stent System. Product Usage: The FSS FLEXSTENT® Femoropopliteal SES clinical product is indicated for treatment of atherosclerotic de novo native superfic... 2 06/06/2013 Cordis Corporation
Z-1511-2013 - FLEXSTENT Femoropopliteal Self-Expanding Stent System. Product Usage: The FSS FLEXSTENT® Femoropopliteal SES clinical product is indicated for treatment of atherosclerotic de novo native superfic... 2 06/06/2013 Cordis Corporation
Z-1510-2013 - FLEXSTENT Femoropopliteal Self-Expanding Stent System. Product Usage: The FSS FLEXSTENT® Femoropopliteal SES clinical product is indicated for treatment of atherosclerotic de novo native superfic... 2 06/06/2013 Cordis Corporation
Z-1509-2013 - FLEXSTENT Biliary Self-Expanding Stent System. Product Usage: The FSS FLEXSTENT Biliary SES product is indicated for use in the palliation of malignant strictures in the biliary tree. 2 06/06/2013 Cordis Corporation
-
-